...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Rampant bull on the science, but some concerns over the money end linger.

 And I think we saw individual cases as the examples.   Right?  Isn't that a little suspect?   One case here and there cherry picked doesn't prove anything. 

Slide 4 shows 2 people in the breast cancer study.  Not suspect. It's waaay early on that trial and as DM stated at 5:50....

"....and I'll be careful to say that not all patients demonstrate objective responses but we are very pleased with percentage that do...."

Our money in Zenith has been locked up for years as the Emperor of Nadir's private stash to toy with.  No sign of that ever changing... right?  

I don't see it changing any time soon.  I doubt we see any cash in our pockets in the next 2 years. 

Share
New Message
Please login to post a reply